TSHR-based chimeric antigen receptor T cell specifically deplete auto-reactive B lymphocytes for treatment of autoimmune thyroid disease
- Resource Type
- Article
- Source
- In
International Immunopharmacology November 2023 124 Part A - Subject
- Language
- ISSN
- 1567-5769